Orgenesis Inc. (OTCQB: ORGS) is a cell therapy and regenerative medicine company that is committed to developing a cure for Type 1 Diabetes, according to the company’s website (see here: www.Orgenesis.com). In this SNNLive On-Location, our host spoke with Scott P. Carmer, CEO, North America of Orgenesis Inc. in New York City, NY.
In this video interview, Mr. Carmer and our host discuss the following topics:
- Overview of Orgenesis Inc.
- Focus on developing cure for Type 1 diabetes
- Mr. Carmer’s background
- Discusses the company’s science
- Update since last SNNLive Video Interview
For more information about Orgenesis Inc., go to: www.Orgenesis.com
© 2017 Stock News Now
Supported by Superior Web Solutions